Follow
Jaume Guixa Mora
Jaume Guixa Mora
Catedrātic
Verified email at upc.edu - Homepage
Title
Cited by
Cited by
Year
Mutational heterogeneity in cancer and the search for new cancer-associated genes
MS Lawrence, P Stojanov, P Polak, GV Kryukov, K Cibulskis, ...
Nature 499 (7457), 214-218, 2013
57212013
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
MS Soengas, P Capodieci, D Polsky, J Mora, M Esteller, X Opitz-Araya, ...
Nature 409 (6817), 207-211, 2001
12662001
Intertumoral heterogeneity within medulloblastoma subgroups
FMG Cavalli, M Remke, L Rampasek, J Peacock, DJH Shih, B Luu, ...
Cancer cell 31 (6), 737-754. e6, 2017
10332017
The whole-genome landscape of medulloblastoma subtypes
PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, ...
Nature 547 (7663), 311-317, 2017
9402017
Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma
A Mackay, A Burford, D Carvalho, E Izquierdo, J Fazal-Salom, KR Taylor, ...
Cancer cell 32 (4), 520-537. e5, 2017
8372017
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors
JF Shern, L Chen, J Chmielecki, JS Wei, R Patidar, M Rosenberg, ...
Cancer discovery 4 (2), 216-231, 2014
6792014
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
A Bruna, RS Darken, F Rojo, A Ocaņa, S Peņuelas, A Arias, R Paris, ...
Cancer cell 11 (2), 147-160, 2007
5792007
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
MG Filbin, I Tirosh, V Hovestadt, MKL Shaw, LE Escalante, ...
Science 360 (6386), 331-335, 2018
5352018
Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes
PD Johann, S Erkek, M Zapatka, K Kerl, I Buchhalter, V Hovestadt, ...
Cancer cell 29 (3), 379-393, 2016
5202016
The genomic landscape of pediatric Ewing sarcoma
BD Crompton, C Stewart, A Taylor-Weiner, G Alexe, KC Kurek, ...
Cancer discovery 4 (11), 1326-1341, 2014
5012014
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
KR Taylor, A Mackay, N Truffaux, YS Butterfield, O Morozova, C Philippe, ...
Nature genetics 46 (5), 457-461, 2014
4992014
A DNA methylation fingerprint of 1628 human samples
AF Fernandez, Y Assenov, JI Martin-Subero, B Balint, R Siebert, ...
Genome research 22 (2), 407-419, 2012
4702012
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
F Mohammad, S Weissmann, B Leblanc, DP Pandey, JW Højfeldt, ...
Nature medicine 23 (4), 483-492, 2017
4572017
A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers
RS Lee, C Stewart, SL Carter, L Ambrogio, K Cibulskis, C Sougnez, ...
The Journal of clinical investigation 122 (8), 2983-2988, 2012
4392012
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
JA Perry, A Kiezun, P Tonzi, EM Van Allen, SL Carter, SC Baca, ...
Proceedings of the National Academy of Sciences 111 (51), E5564-E5573, 2014
4272014
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
V Ramaswamy, M Remke, E Bouffet, CC Faria, S Perreault, YJ Cho, ...
The lancet oncology 14 (12), 1200-1207, 2013
3902013
Cytogenetic prognostication within medulloblastoma subgroups
DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ...
Journal of clinical oncology 32 (9), 886, 2014
3562014
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
EM Thompson, T Hielscher, E Bouffet, M Remke, B Luu, S Gururangan, ...
The lancet oncology 17 (4), 484-495, 2016
3482016
Sarcoma classification by DNA methylation profiling
C Koelsche, D Schrimpf, D Stichel, M Sill, F Sahm, DE Reuss, M Blattner, ...
Nature communications 12 (1), 498, 2021
2822021
EMP3, a myelin-related gene located in the critical 19q13. 3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma
M Alaminos, V Dávalos, S Ropero, F Setién, MF Paz, M Herranz, ...
Cancer research 65 (7), 2565-2571, 2005
2092005
The system can't perform the operation now. Try again later.
Articles 1–20